Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2023.466 | Predictors of clinical success in patients with unilateral primary hyperaldosteronism treated with adrenalectomy | Dr. CHOW Edith Wing Kar |
| 2021.050 | Prediction of Adverse Drug Effects in Older adults using Machine Learning Algorithms | Dr. CHOW Elaine |
| 2021.192 | Effect of Glucagon-like peptide 1 receptor agonist in combination with insulin on Glycaemic variability and Time-in-range in Diabetic Kidney Disease: a randomised controlled trial | Dr. CHOW Elaine |
| 2023.147 | Familial Chylomicronaemia Syndrome (FCS)/multifactorial chylomicronaemia syndrome (MCS) International service evaluation/quality improvement project | Dr. CHOW Elaine |
| 2024.401 | Evaluating a novel, allosteric glucokinase activator in monogenic diabetes secondary to inactivating glucokinase mutations: a randomised, cross-over trial | Dr. CHOW Elaine |
| 2023.615 | Use of clinical-trials and simulation models to estimate cost-effectiveness of non-steroidal mineralocorticoid antagonists, RASi and SGLT2i as triple therapy with type 2 diabetes and chronic kidney disease |
Dr. CHOW Elaine 周怡君 |
| 2024.298 | Evaluation of Accuracy of Medtronic Simplera™ CGM in patients on icodextrin-containing peritoneal dialysis regimens | Dr. CHOW Elaine |
| 2024.289 | Effects of repeated dose of dorzagliatin on insulin secretion, glucagon release and incretin function in intermediate hyperglycemia and type 2 diabetes | Dr. CHOW Elaine |
| 2023.545 | A prospective, observational study to examine factors associated with progression and regression from prediabetes in Hong Kong |
Dr. CHOW Elaine Elaine Chow |
| 2026.012 | A Multi-national, non-interventional stUdy of bempedoic acid or its Single-pill combinAtion therapy with ezetimibe in routine clinical practice in patientS with primary Hypercholesterolaemia or mIxed dyslipidaemia – Musashi Study | Dr. CHOW Elaine |
| 2026.044 | Evaluation of Accu-Check SmartGuide with or without glucose prediction in improving postprandial control in suboptimally controlled young-onset type 2 diabetes on basal-prandial insulin in Hong Kong | Prof. CHOW Elaine |
| 2025.201 | Implementing a multidimensional electronic health record based machine-learning model to identify older adults at risk of falls | Dr. CHOW Elaine |
| 2026.408 | A retrospective observational study of characteristics, treatment patterns, and clinical outcomes of adults with hypertension and normal or abnormal glucose tolerance in Hong Kong | Dr. CHOW Elaine |
| 2026.195 | Glycemic assessment based on continuous glucose monitoring and clinical outcomes in people with diabetes on peritoneal dialysis: a multi-centered prospective study | Dr. Chow Elaine |
| 2020.365 | Evaluation of Accuracy of Guardian Sensor 3 in diabetes patients on peritoneal dialysis | Dr. CHOW Elaine |
| 2018.464 | European Atherosclerosis Society Familial Hypercholesterolemia Studies Collaboration (EAS FHSC) Registry | Dr. CHOW Elaine |
| 2019.688 | Pharmacokinetic and pharmacodynamic study of a novel sublingual aspirin tablet compared to conventional oral aspirin in healthy subjects | Prof. CHOW Elaine |
| 2023.408 | A Clinical Study on Contactless Vital Sign Measurements with Remote Photoplethysmography (rPPG) Using a Camera | Dr. CHOW Elaine Y.K. |
| 2021.709 | A Multi-center, Randomized, Double-Blinded, Parallel, Vildagliptin and Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of PB-201 in Treatment-naive Patients with Type 2 Diabetes Mellitus |
Prof. CHOW Elaine Yee Kwan 周怡君 |
| 2021.716 | The Impact of High or Low FODMAP diets on Postprandial glucose response and Gut Microbiota in Individuals with Prediabetes treated with Metformin: A Randomized Crossover Controlled-Feeding Trial |
Dr. CHOW Elaine Yee Kwan 周怡君 |
| 2022.293 | A Multi-center, Randomized, Double-Blinded, Parallel and Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients with Poor Glycemic Control via Metformin Hydrochloride Monotherapy | Prof. CHOW Elaine Yee Kwan |
| 2015.563 | Beta cell function and insulin sensitivity in Chinese with young onset type 2 diabetes and their siblings – a pilot study | Dr. CHOW Elaine Yee Kwan |
| 2017.359 | A pilot study to describe the glycemic variability of insulin glargine 300U/ml versus NPH (Neutral Protamine Hagedorn) in the insulin-naive type 2 diabetes patients following a patient-adjusted insulin algorithm in Hong Kong | Dr. CHOW Elaine Yee Kwan |
| 2016.572 | Effectiveness and safety study of the percutaneous optical fibre glucose sensor (FiberSense) for home use in diabetic and prediabetic individuals | Dr. CHOW Elaine Yee Kwan |
| 2011.235 | Genetic analysis of familial hypercholesterolaemia in Hong Kong Chinese population | Dr. CHOW Elaine Yee Kwan |
| 2018.106 | Targeted screening for familial hypercholesterolaemia in Hong Kong Chinese patients with established coronary artery disease |
Dr. CHOW Elaine Yee Kwan 周怡君 |
| 2018.526 | A randomized, 24 week, active-controlled, open-label, 3-arm, parallel-group multicenter study comparing the efficacy and safety of iGlarLixi to insulin glargine and lixisenatide in type 2 diabetes mellitus patients insufficiently controlled with oral antidiabetic drug(s) |
Dr. CHOW Elaine Yee Kwan 周怡君 |
| 2018.621 | Randomised controlled trial of flash glucose monitoring in reduction of hypoglycaemia in diabetes patients with chronic kidney disease |
Dr. CHOW Elaine Yee Kwan 周怡君 |
| 2020.312 | Effectiveness and Safety Study of the Continuous Glucose Monitoring System for Home Use (Including In-clinic sessions) in Patients with Diabetes | Prof. CHOW Elaine Yee Kwan |
| 2019.352 | A Phase Ib/IIa, Single Ascending Dose Study of the Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients with Type 2 Diabetes Mellitus | Dr. CHOW Elaine Yee Kwan |
| 2019.605 | Continuous glucose monitoring as an adjunct to lifestyle modification in individuals with impaired glucose tolerance: a randomised controlled trial |
Dr. CHOW Elaine Yee Kwan 周怡君 |
| 2019.222 | The effect of real-time continuous glucose monitoring (rtCGM) on improving time-in-range in suboptimally controlled type 2 diabetes patients on multiple daily injections (MDI) |
Dr. CHOW Elaine Yee Kwan 周怡君 |
| 2022.464 | A study of the safety and tolerability of gold nanoparticles in a topical hydrogel in healthy volunteers | Dr. CHOW Elaine Yee Kwan |
| 2007.494 | A Randomised, Double-blind, Active-Controlled Parallel Group Efficacy and Safety Study of BI 1356 (5.0 mg, administered orally once daily) Compared to Glimepiride (1 to 4 mg once daily) Over Two Years, In Type 2 Diabetic Patients with Insufficient Glycaemic Control Despite Metformin Therapy | Dr. Chow Francis C. C. |
| 2009.112 | A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide Administered in Combination with Metformin and Glimepiride Compared with Metformin Plus Glimepiride and Placebo and with Metformin Plus Glimepiride and Pioglitazone in Subjects with Type 2 Diabetes Mellitus | Dr. Chow Francis Chun Chung |
| 2010.137 | BEGIN | Dr. Chow Francis Chun Chung |
| 2009.533 | BOOST: INTENSIFY ALL A Pan Asian trial comparing efficacy and safety of NN5401 and biphasic insulin aspart 30 in type 2 diabetes. A 26-week trial, randomised, open-label, two-arm, parallel-group, treat-to-target study comparing efficacy and safety of the soluble insulin analogue combination (SIAC) twice daily with biphasic insulin aspart 30 twice daily, with or without metformin in subjects with type 2 diabetes in inadequate glycaemic control on once or twice daily insulin regimen with or without metformin | Dr. Chow Francis Chun Chung |
| 2009.532 | BEGIN: ONCE ASIA A Pan Asian trial comparing efficacy and safety of insulin NN1250 and insulin glargine as add on to OAD(s) in subjects with type 2 diabetes. A 26-week randomised, confirmatory, controlled, open label, multicentre, multinational treat-to-target trial comparing the efficacy and safety of SIBA and insulin glargine, both injected once daily as add on to current OAD treatment in insulin na・e subjects with type 2 diabetes mellitus qualifying for more intensified treatment | Dr. Chow Francis Chun Chung |
| 2009.458 | A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Adminstered in Combination With Insulin Glargine as Compared with the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes Mellitus | Dr. Chow Francis Chun Chung |
| 2010.511 | A multicentre, international, randomised, parallel group, double blind study to evaluate Cardiovascular safety of linagliptin versus glimepiride in patients with type 2 diabetes mellitus at high cardiovascular risk. The CAROLINA Trial. | Dr. CHOW Francis Chun Chung |
| 2009.262 | A 52 week randomised, controlled, open label, multicentre, multinational treat-to-target trial comparing efficacy and safety of SIBA and insulin glargine both administered once daily in a basal-bolus regimen with insulin aspart as mealtime insulin ± treatment with metformin, ± pioglitazone or both in subjects with type 2 diabetes currently treated with insulin qualifying for intensified treatment | Dr. Chow Francis Chun Chung |
| 2009.144 | SCALE -Obesity and Pre-diabetes Satiety and Clinical Adiposity- Liraglutide Evidence in Nondiabetic and Diabetic Subjects Effect of liraglutide on body weight in non-diabetic obese subjects or overweight subjects with comorbidities A randomised, double-blind, placebo controlled, parallel group, multi-centre, multinational trial with stratification of subject to either 56 or 160 weeks of treatment based on pre-diabetes status at randomisation | Dr. CHOW Francis Chun Chung |
| 2013.409 | Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin and/or TZD in subjects with type 2 diabetes | Dr. CHOW Francis Chun Chung |
| 2009.111 | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Two Dose Levels of Albiglutide Compared with Placebo in Subjects with Type 2 Diabetes Mellitus | Dr. Chow Francis Chun Chung |
| 2015.370 | A 24-week, multinational, multicentre, randomised, open label, parallel-group treat to target trial to compare efficacy and safety of thrice daily versus twice daily NovoMix®30 (Biphasic insulin aspart 30) in subjects with type 2 diabetes inadequately controlled with basal insulin |
Dr. CHOW Francis Chun Chung 周振中 |
| 2017.233 | Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes |
Dr. CHOW Francis Chun Chung 周振中 |
| 2015.470 | Efficacy and safety of semaglutide versus dulaglutide as add-on to metformin in subjects with type 2 diabetes |
Dr. CHOW Francis Chun Chung 周振中 |
| 2012.274 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects with Type 2 Diabetes and with Cardiovascular Disease or Multiple Risk Factors for Cardiovascular Events | Dr. CHOW Francis Chun-Chung |
| 2008.537 | Patient's and Surgeons' Expectation and Concerns in ACL Reconstruction Surgery | Chow Hon Yuen |
| 2017.029 | The effect of a new ankle foot orthosis on gait symmetry for stroke patient |
Mr. CHOW Hung Yu 周鴻譽 |
Page 86 of 288.